Navigation Links
Kenya halts first field trials of GM maize

Kenyan authorities began destroying the country's first genetically modified (GM) maize growing in open field trials.

The government halted the research and ordered the destruction after discovering that a technician had sprayed a restricted pesticide on maize modified to resist attack by insects called stem borers.

Wilson Songa, Kenya's agriculture secretary and chair of the National Biosafety Committee, said this could compromise the validity of the trial's results.

On 25 August, the committee ordered the Kenya Plant Health Inspectorate Service to destroy the crops.

Songa was quoted in Kenya's Sunday Nation newspaper on 28 August as saying that local scientists had yielded to pressure from international organisations and were "rushing projects".

The maize was being grown in Kiboko by the Insect Resistance Maize for Africa (IRMA) project, a joint initiative of the Kenyan Agricultural Research Institute, the US-based Syngenta foundation, and the Mexico-based Center for Maize and Wheat Research.

In July, IRMA staff had notified the biosafety committee that the maize had been sprayed with the insecticide Furadan.

Stephen Mugo, IRMA's project coordinator, says the incident was unfortunate and a major setback to Kenyan research, but that GM maize field trials would continue.

"This is just like a battle we lost," said Mugo. "But the main war will continue until we help African maize farmers overcome the pest".

Stem borers destroy up to 12 per cent of maize growing in Kenya, amounting to US$76 million in lost harvests per year.

The IRMA project, which began six years ago, aims to develop both conventional and GM maize varieties to resist the pest.

The GM plants, which incorporate genetic material from a bacterium called Bacillus thuringiensis, have already been grown under experimental conditions in IRMA's US$12 million 'biosafety' greenhouse (see $12 million greenhouse signals Kenyan GM commitment).

When the first IRMA maize seeds were sown outside in May, Kenya became the first African country after South Africa to plant GM maize in open fields (see Kenya begins first open field trials of GM maize).
The IRMA researchers had hoped to release the maize to farmers by 2010 (see Revision of plans delays Kenya's GM maize).


'"/>

Source:SciDev.Net


Related biology news :

1. Intrinsic eye protein halts angiogenesis
2. Trojan Horse agent halts bone metastasis in mice
3. A genes first kiss sets off that affair known as puberty
4. Love at first smell
5. Worlds largest rainforest drying experiment completes first phase
6. PCRM develops worlds first cruelty-free insulin assay
7. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
8. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
9. DuPonts first biologically derived polymer receives global recognition
10. Anti cancer virotherapy well tolerated in first human administration, research finds
11. Unlike other mammals, newborn dolphins and orcas stay active 24/7 during first months of development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems ... seamlessly log work hours, for employers to make sure the right employees are actually ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is pleased ... received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of ... Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform ...
Breaking Biology Technology: